Dr. Williamson has extensive experience in pharmaceutical discovery.He served as Vice President of Basic Research and Vice President, Research Strategy Worldwide, for Merck. Previously he was with Glaxo, UCLA, University of Glasgow, and the National Institute for Medical Research, U.K.e is the recipient of the Colworth Medal of the Biochemical Society and a member of the EMBL. He was elected Fellow of the Royal Society of Edinburgh in 1976 and Fellow of the Institute of Biology in 1982.Dr. Williamson sits on the board or scientific advisory board of several companies in addition to Onconova, including Argenta Discovery, Devgen and Solexa. He is a consultant to the venture capital firm Abingworth Management Ltd.